Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

SPACs Are in a Bubble, but These 3 Stocks Will Make It Through
SPACs Are in a Bubble, but These 3 Stocks Will Make It Through

It's been an incredible year for special purpose acquisition companies, or SPACs, which in 2020 have become a preferred vehicle for early-stage companies wanting access to public markets.

A SPAC

$450 Invested Monthly in This ETF Can Pay Your Rent in Retirement
$450 Invested Monthly in This ETF Can Pay Your Rent in Retirement

You're targeting retirement in 25 short years and you don't own a home. The quandary is, should you buy a home so that someday you can do away with the cost of rent? Or should you focus solely on

The 1 Stock I'd Buy Right Now
The 1 Stock I'd Buy Right Now

The stock market has, overall, been on a tear this year. Despite a recession, a pandemic, and a contentious presidential election, investors have been very optimistic, pushing the S&P 500 up 8.7% so

Is Guardant Health Stock a Buy?
Is Guardant Health Stock a Buy?

Many cancer patients undergoing treatment have impaired immune systems, so it's not a big surprise that some of them stayed away from clinic settings during the spring, when cases of COVID-19 were

Is Canopy Growth Stock a Buy?
Is Canopy Growth Stock a Buy?

Canadian marijuana company Canopy Growth (NYSE: CGC) sells everything from raw cannabis flowers to THC-infused beverages and cannabidiol hand creams. With its diverse collection of brands, it's

The Best Pot Stock for the Next 10 Years
The Best Pot Stock for the Next 10 Years

While Canada technically made medical cannabis legal in 2001, its federal courts didn't allow producers to market cannabis until 2016. Recreational cannabis, which included flowers, oils, plants,

Why I Think Bristol Myers Squibb Is Too Cheap to Miss
Why I Think Bristol Myers Squibb Is Too Cheap to Miss

For investors in pharmaceutical companies, few things are more concerning than a loss of market share, particularly if it's because of the patent expiration of a blockbuster drug. Bristol Myers

Quidel and OPKO Health Are Scoring With Coronavirus Testing in Sports. Is the Market Missing It?
Quidel and OPKO Health Are Scoring With Coronavirus Testing in Sports. Is the Market Missing It?

After shutting down its season on March 11, the NBA resumed games four months later, isolated in a Walt Disney World complex. After that four-month experiment in sequestering teams, coaches, and

Why Are Pot Stocks Popping?
Why Are Pot Stocks Popping?

October has been a good month for the marijuana industry, with the Horizons Marijuana Life Sciences ETF up about 13% so far against the S&P 500's 4% climb. Many pot stocks, including Canopy Growth 

Better Coronavirus Stock: AstraZeneca or Moderna?
Better Coronavirus Stock: AstraZeneca or Moderna?

Over the last few months, AstraZeneca (NYSE: AZN) and Moderna (NASDAQ: MRNA) have emerged as frontrunners in the race for a coronavirus vaccine. Both vaccine efforts are in the midst of the final

Got $3,000? 3 Edge Computing Stocks to Buy Right Now
Got $3,000? 3 Edge Computing Stocks to Buy Right Now

With over a decade of rapid cloud expansion, the next wave of data center-powered computing is now under way: edge computing. Put simply, edge computing brings data out of a centralized cloud to a

26% of Americans Misunderstand Medicare -- and It Could Ruin Their Retirement
26% of Americans Misunderstand Medicare -- and It Could Ruin Their Retirement

When you're saving for retirement, it's imperative to consider all costs you're likely to incur in your later years. Unfortunately, just over a quarter of Americans are laboring under a major

Why You Should Buy Starbucks Before the Earnings Release
Why You Should Buy Starbucks Before the Earnings Release

After losing almost 40% of its price in the March crash, Starbucks (NASDAQ: SBUX) stock turned positive year to date just last week. Revenue is steadily improving, and the company beat on sales and

Where Will Anheuser-Busch InBev Be in 1 Year?
Where Will Anheuser-Busch InBev Be in 1 Year?

Anheuser-Busch InBev (NYSE: BUD), the world's largest brewer, has lost 40% of its stock value over the past 12 months as it struggled with sluggish sales of beer, high commodity costs, and

Aurora Cannabis: Buy the Dip?
Aurora Cannabis: Buy the Dip?

Investing guru Warren Buffett once said, "We simply attempt to be fearful when others are greedy and to be greedy only when others are fearful." In the context of Aurora Cannabis' (NYSE: ACB) fall

Where Will Aurora Cannabis Be in 1 Year?
Where Will Aurora Cannabis Be in 1 Year?

Canadian cannabis company Aurora Cannabis (NYSE: ACB) saw a bright future ahead when Canada legalized adult-use recreational marijuana in October 2018. But Aurora's acquisition spending spree, rapid

Got $5,000? Here Are 2 Dividend Growth Stocks to Buy and Hold for Decades
Got $5,000? Here Are 2 Dividend Growth Stocks to Buy and Hold for Decades

If you are in a financial position to invest $5,000 in new stocks today, you will find no shortage of exciting options. If you would like to balance the potential for solid returns with long-term

Why I'm Buying Shares of Ontrak and Unity Software
Why I'm Buying Shares of Ontrak and Unity Software

It's no secret that companies involved in cloud computing, virtual direct-to-consumer sales, artificial intelligence (AI), and augmented reality (AR) are onto something big. Two exciting stocks come

Could This Healthcare SaaS Stock Be the Next Veeva Systems?
Could This Healthcare SaaS Stock Be the Next Veeva Systems?

It's no longer a secret that the software-as-a-service (SaaS) business model has huge advantages. It costs next to nothing to give a new customer access; upgrades are the norm; and wide moats form

3 Green Flags for Aurora Cannabis' Future
3 Green Flags for Aurora Cannabis' Future

For investors in troubled Canadian marijuana cultivator Aurora Cannabis (NYSE: ACB), good news is in short supply. The company is nowhere near profitability, and its stock has been falling since

10 Reasons Bitcoin Is a Terrible Investment
10 Reasons Bitcoin Is a Terrible Investment

It's been a challenging year for Wall Street. We've witnessed the quickest bear market decline of at least 30% in history, as well as the most ferocious comeback of all time, with the benchmark S&P

Netflix Versus Amazon Prime: The Race to 200 Million Subscribers
Netflix Versus Amazon Prime: The Race to 200 Million Subscribers

While many businesses struggle to survive the consequences of the COVID-19 pandemic, Netflix (NASDAQ: NFLX) and Amazon (NASDAQ: AMZN) are thriving. The two benefit as people worldwide are hesitant

Is Amwell Stock a Buy?
Is Amwell Stock a Buy?

Investors (and people!) looking back on 2020 years from now will no doubt call it a year like no other in their lifetimes. The coronavirus pandemic has disrupted habits -- and perhaps helped form

3 Investing Moves to Make by the End of 2020
3 Investing Moves to Make by the End of 2020

It's fair to say that 2020 has been a miserable year for many of us, so much so that at this point, a lot of people are probably ready to wish it away. But for better or worse, we only have about 11

3 Top Growth Stocks You Can Buy and Hold for the Next Decade
3 Top Growth Stocks You Can Buy and Hold for the Next Decade

You need three things to buy and hold a stock for a decade: conviction, trust, and patience. You must be strongly convinced that the underlying company has solid growth catalysts for several years